(BQE.TO | BTQNF)
"BioteQ is a water treatment company that applies innovative technologies and operating expertise to solve challenging water treatment problems in the resource and power generation industries.
BioteQ works with the world’s leading resource companies, utility operators, and regulators to reduce environmental liabilities while generating revenue from wastewater. BioteQ’s customers include Xstrata, Freeport-McMoRan Copper & Gold, Jiangxi Copper, Capstone Mining, Breakwater, and the US Environmental Protection Agency.
BioteQ’s commercially proven technologies treat industrial wastewater contaminated with dissolved heavy metals and sulphate. Contamination can result from industrial, resource, and power generation activities. The outputs of BioteQ’s unique processes are saleable by-products and clean water that can be sold, recycled or discharged to the environment. Metals that can be removed include copper, zinc, nickel, cobalt, arsenic, antimony, lead, cadmium, selenium, mercury, manganese, molybdenum, rhenium, iron, and aluminum.
BioteQ earns revenues from water treatment fees, the sale of byproducts and water treatment plants, and from engineering fees.
BioteQ’s services:
• Provide sustainable water treatment solutions that enable customers to comply with environmental regulations
• Eliminate or reduce the environmental liability caused by metal and sulphate contaminated water
• Generate revenue from recovered metals and saleable byproducts, which can off set water treatment costs
• Produce high quality treated water for re-use or discharge
• Reduce life cycle costs compared to other processes
BioteQ has built 10 commercial plants in Canada, the US, Australia, China, and Mexico and has new projects in its development and construction pipeline at locations in Canada, the US, China, and Chile."
- BioteQ Investor Fact Sheet - 2010
Highlights
• 10 commercial plants for high-value customers
• several pilots ongoing and commercial plants in the pipeline
• Revenues in 2010 expected to be $8MM+
• $12MM in working capital as of June 30, 2010
• No debt
• Potential to increase revenue 5-10X within two years (rough guesstimate)
• Alliances with Newalta and Lanxess for the mining, oil & gas and power generation sectors.
Share Structure - as of January 2010
Shares O/S: 69,736,364
Warrants: 3,636,364
Options:
Shares FD: 71,300,000
Management ownership: 10%
1/22/10 financing with Newalta
3,636,364 shares at 1.10 for $4MM to BioteQ
3,636,364 wts $1.37 until 1/2011 then $1.65 until 1/2015 expiry
Resources
BioteQ web site
BioteQ corporate video
BioteQ fact sheet
BioteQ corporate presentation - Jan 2010 (pdf)
Q&A on the BioteQ/Newalta strategic alliance (pdf)
Charts: Daily, Weekly |
